| Molecule Generation from Input-Attributions over Graph Convolutional Networks | Jan 25, 2022 | Drug Design | —Unverified | 0 |
| Semi-Supervised GCN for learning Molecular Structure-Activity Relationships | Jan 25, 2022 | Drug DesignGraph Neural Network | —Unverified | 0 |
| Reinforcement Learning for Personalized Drug Discovery and Design for Complex Diseases: A Systems Pharmacology Perspective | Jan 21, 2022 | Drug DesignDrug Discovery | —Unverified | 0 |
| AlphaFold Accelerates Artificial Intelligence Powered Drug Discovery: Efficient Discovery of a Novel Cyclin-dependent Kinase 20 (CDK20) Small Molecule Inhibitor | Jan 21, 2022 | Drug DesignDrug Discovery | —Unverified | 0 |
| Frequent Itemset-driven Search for Finding Minimum Node Separators in Complex Networks | Jan 18, 2022 | Drug DesignManagement | —Unverified | 0 |
| A Constraint Programming Approach to Weighted Isomorphic Mapping of Fragment-based Shape Signatures | Dec 20, 2021 | Drug Design | —Unverified | 0 |
| Learning to Detect Critical Nodes in Sparse Graphs via Feature Importance Awareness | Dec 3, 2021 | Drug DesignFeature Importance | —Unverified | 0 |
| HelixMO: Sample-Efficient Molecular Optimization in Scene-Sensitive Latent Space | Nov 30, 2021 | Drug DesignDrug Discovery | —Unverified | 0 |
| Equivalent Distance Geometry Error for Molecular Conformation Comparison | Nov 13, 2021 | Drug Design | CodeCode Available | 0 |
| AI challenges for predicting the impact of mutations on protein stability | Nov 8, 2021 | Computational EfficiencyDrug Design | —Unverified | 0 |
| Structure-aware generation of drug-like molecules | Nov 7, 2021 | Drug Design | —Unverified | 0 |
| De Novo Molecular Generation with Stacked Adversarial Model | Oct 24, 2021 | Drug Designvalid | —Unverified | 0 |
| Molecular Graph Generation via Geometric Scattering | Oct 12, 2021 | Drug DesignGraph Generation | —Unverified | 0 |
| An In-depth Summary of Recent Artificial Intelligence Applications in Drug Design | Oct 10, 2021 | Drug DesignGenerative Adversarial Network | —Unverified | 0 |
| Mining for Potent Inhibitors through Artificial Intelligence and Physics: A Unified Methodology for Ligand Based and Structure Based Drug Design | Oct 5, 2021 | Deep Reinforcement LearningDrug Design | —Unverified | 0 |
| Hit and Lead Discovery with Explorative RL and Fragment-based Molecule Generation | Oct 4, 2021 | Drug DesignMolecular Docking | —Unverified | 0 |
| Pharmacoprint -- a combination of pharmacophore fingerprint and artificial intelligence as a tool for computer-aided drug design | Oct 4, 2021 | Dimensionality ReductionDrug Design | —Unverified | 0 |
| Knowledge Guided Geometric Editing for Unsupervised Drug Design | Sep 29, 2021 | Drug Design | —Unverified | 0 |
| Deep Denerative Models for Drug Design and Response | Sep 14, 2021 | Drug DesignDrug Response Prediction | —Unverified | 0 |
| Hybrid quantum-classical machine learning for generative chemistry and drug design | Aug 26, 2021 | Drug DesignDrug Discovery | —Unverified | 0 |
| APObind: A Dataset of Ligand Unbound Protein Conformations for Machine Learning Applications in De Novo Drug Design | Aug 23, 2021 | Drug Design | —Unverified | 0 |
| New Candidates for Furin Inhibition as Probable Treat for COVID-19: Docking Output | Jul 27, 2021 | Drug Design | —Unverified | 0 |
| Machine Learning Implicit Solvation for Molecular Dynamics | Jun 14, 2021 | BIG-bench Machine LearningDrug Design | —Unverified | 0 |
| Robust Graph Meta-learning for Weakly-supervised Few-shot Node Classification | Jun 12, 2021 | ClassificationDrug Design | —Unverified | 0 |
| Realistic molecule optimization on a learned graph manifold | Jun 3, 2021 | Drug DesignGraph Generation | —Unverified | 0 |